Over 1050 Total Lots Up For Auction at Two Locations - NJ 08/01, CA 08/09

The Future of nuclear medicine: Driving value in expanded clinical use

June 30, 2017
Molecular Imaging
From the June 2017 issue of HealthCare Business News magazine

Kees Wesdorp
Improved integration within the broader health continuum. With an aging population and the continuing rise in multiple chronic and complex diseases, molecular imaging’s high detail and qualitative results will play a key role in transforming population health. Population health management requires more integrated and interdisciplinary approaches, and as clinicians look to implement more preemptive and definitive treatment programs, they will require access to integrated, comprehensive data on the patient’s diagnostic history, not just an image.

Nuclear medicine and molecular imaging will continue to advance and develop as an integral part of radiology and diagnostic imaging, expanding to bring physicians one step closer to personalized care. Despite its significant growth in past years, the opportunity for further innovation and growth remains, continuing to maximize nuclear medicine’s value and impact.

stats
DOTmed text ad

Cosmetic Surgery, Medical and Bio Tech Lab Surplus Auctions

These online auctions feature Surplus Medical Equipment Extracted from Featuring A Variety of Medical Equipment & Consumables from A Bergen County, NJ Plastic Surgeon & Rensselear, NY BioTech Lab Location: 81 Hamburg Tpk, Riverdale, NJ 07457, US

stats

About the authors: Kees Wesdorp, Ph.D., is the business group leader, Diagnostic Imaging at Philips. Kirill Shalyaev, Ph.D., is the business leader, Advanced Molecular Imaging at Philips.

Back to HCB News

You Must Be Logged In To Post A Comment